Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04964934 |
|---|---|
| Brief Title: | Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6) (SERENA-6) |
| First Submitted : | June 30, 2021 |
| First Submitted that Met QC Criteria : | July 14, 2021 |
| First Posted : | July 16, 2021 |
| Last Update Submitted that Met QC Criteria : | April 29, 2024 |
| Last Update Posted : | April 30, 2024 |